DEPO-MEDROL 40 mg/1 ml, suspension for injection in a vial bottle, 1 ml
Active ingredients: Methylprednisolone acetate
Commercialized according to BDPMDispensing in France: Prescription only
Suspension for injectionbottle, 1 mlendosinusale;intraarticulaire;intralésionnelle;intramusculaire;périarticulaire;voie parentérale autre
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DEPO-MEDROL 40 mg/1 mL, suspension injectable en flacon
- Pharmaceutical form
- suspension injectable
- Route of administration
- endosinusale;intraarticulaire;intralésionnelle;intramusculaire;périarticulaire;voie parentérale autre
- Presentation description
- 1 flacon(s) en verre de 1 ml
- Marketing authorisation holder
- PFIZER HOLDING FRANCE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 31 Aug 2004
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64085814CIP73369786CIP133400933697860Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ACÉTATE DE MÉTHYLPREDNISOLONEsuspension | 40,0 mg · 1 ml de suspension injectable | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.